from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2111c/pup

LFCtreatmentdescriptionclass of inhibitor

0.716

Amikacinug/mL Amikacintranslation

0.207

Cap5-10ug/mL Capreomycintranslation

0.081

Rox10-50 ug/mL Roxithromycintranslation

0.289

SM2-5 ug/mL Streptomycintranslation

0.652

Tet5-10 ug/mL Tetracyclinetranslation

-1.869

Rif0.2-5ug/mL Rifampicintranscription

-1.291

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.372

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.570

CPZ10-50 ug/mL Chlorpromazinerespiration

0.032

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.161

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.572

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.246

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.925

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.049

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.191

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.100

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.068

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.096

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.294

KCN5-20 ug/mL Potassium cyaniderespiration

0.021

NaN30.2-2 mM Sodium aziderespiration

0.388

Nigericin50 uM Nigericinrespiration

0.038

TRC10-150 ug/mL Triclosanrespiration

1.460

TRZ10-25 ug/mL Thioridazinerespiration

1.113

Valinomycin0.5-10 uM Valinomycinrespiration

-0.109

ZnSO42 mM ZnSO4respiration

1.421

menadione6-10 ug/mL Menadionerespiration

-0.156

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.252

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.026

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.458

NRP_1Non-replicating persistence stage 1dosRassociated

0.424

Amp0.2mg/mL AmpicillincellWall

-0.348

Cephalexin20-100 ug/mL CephalexincellWall

0.107

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.868

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.275

EMB10-20 ug/mL EthambutolcellWall

0.718

Eta12-40 ug/mL EthionamidecellWall

1.377

INH0.2-0.4 ug/mL IsoniazidcellWall

0.051

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.193

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.278

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.789

BZA0.12 mg/mL BenzamidearomaticAmides

0.645

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.517

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.592

H2O24 mM hydrogen peroxideDNAdamaging

0.497

Levo10 ug/mL LevofloxacinDNAdamaging

-0.446

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.738

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.867

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.929

UVUV-irradiationDNAdamaging

0.564

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.806

Antimycin12.5-50 ug/mL Antimycin A?

-0.505

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.237

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.438

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.192

PA8240.2-2 ug/mL PA-824?

0.322

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.260

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.152

Verapamil50 uM Verapamil?

-0.214

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.750

methoxatin10-20 ug/mL Methoxatin?